SMTL ID : 4ot6.1

Crystal structure of BTK kinase domain complexed with 4-Methanesulfonyl-N-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-benzamide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

monomer

Ligands

1 x 2V1: 4-(methylsulfonyl)-N-[3-(8-{[4-(morpholin-4-ylcarbonyl)phenyl]amino}imidazo[1,2-a]pyrazin-6-yl)phenyl]benzamide(Non-covalent)

2V1.1: 14 residues within 4Å: Chain A: E.31, L.32, G.33, T.34, V.40, A.52, T.98, E.99, Y.100, M.101, A.102, G.104, N.108, L.152 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.32, A:V.40, A:Y.100 Hydrogen bonds: A:M.101, A:M.101, A:G.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lou, Y. et al., Structure-Based Drug Design of RN486, a Potent and Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. J.Med.Chem. (2015)

Release Date

2014-05-14

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence